Table 3 |
|||
|
Cytokine response following daily supplementation with 0, 2 or 8 mg astaxanthin after 0, 4 and 8 wk. |
|||
|
Treatment |
Wk 0 |
Wk 4 |
Wk 8 |
|
|
|||
|
TNF-α (pg/mL); Overall SE = 0.43 |
|||
|
0 mg |
1.14 |
1.63 |
1.43 |
|
2 mg |
0.80 |
1.13 |
1.44 |
|
8 mg |
1.51 |
2.15 |
2.60 |
|
IFN-γ (pg/mL); Overall SE = 0.34 |
|||
|
0 mg |
5.85 |
4.47 |
4.68b |
|
2 mg |
4.87 |
4.26 |
5.00b |
|
8 mg |
4.67 |
6.23 |
9.55a |
|
IL-6 (pg/mL); Overall SE = 2.9 |
|||
|
0 mg |
10.5 |
12.7 |
13.6b |
|
2 mg |
10.0 |
11.5 |
8.7b |
|
8 mg |
11.5 |
12.4 |
25.2a |
|
IL-2 (pg/mL); Overall SE = 0.10 |
|||
|
0 mg |
8.61 |
8.04 |
7.74 |
|
2 mg |
5.09 |
4.67 |
4.46 |
|
8 mg |
4.91 |
4.01 |
3.90 |
|
|
|||
|
a, b Different letters represent significant treatment differences (P < 0.05) as analyzed by ANOVA. Values are means; variation is expressed as a representative overall standard error. |
|||
|
Park et al. Nutrition & Metabolism 2010 7:18 doi:10.1186/1743-7075-7-18 |
|||